Navigation Links
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
Date:4/26/2009

purpura, rheumatoid arthritis, interstitial nephritis, lupus-like syndrome, sarcoidosis, aggravated psoriasis, urticaria, injection site necrosis, vasculitis and phototoxicity.

Additional serious adverse events included hallucinations. bipolar disorder, mania, encephalopathy (usually elderly treated with higher doses of PEGINTRON), hypotension, tachycardia, retinopathy including macular edema, retinal hemorrhage, cotton wool spots, papilledema, ischemic and hemorrhagic cerebrovascular events, bone marrow toxicity (cytopenia and very rarely aplastic anemia), thyroiditis, dental and periodontal disorders, hemorrhagic/ischemic colitis, dyspnea, pulmonary infiltrates, pneumonia, interstitial pneumonitis, hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia.

During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years receiving PEGINTRON/REBETOL combination therapy, weight loss and growth inhibition were common.

Patients receiving PEGINTRON and REBETOL as retreatment after failing a previous interferon combination regimen reported adverse reactions similar to those previously associated with this regimen during clinical trials of treatment-naive patients.

Please see important full U.S. prescribing information and the Medication Guide for PEGINTRON at www.schering-plough.com.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, an
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. ... in China , today announced that it ... ended March 31, 2013, before market on Tuesday, May 28, ... May 28, 2013, at 8:00 a.m. EDT (May 28, 2013 ... financial results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 6Webs.com ... The simple to read reviews and comprehensive comparisons make ... impartial home security reviews. 6Webs.com just recently finished conducting ... system providers. , Tim Smythe from 6Webs.com reports, "There ... systems due to their ease of use, expandability and ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric ... that is all about is getting results in the fastest ... http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting an investigative review. , ... phase system” designed to make you faster, stronger, fitter and ... out in the gym. The training manual and exercise video ...
(Date:5/18/2013)... The California College of Ayurveda Spa ... Ayurvedic Spa , the client receives stress relief ... and lifestyle recommendations and stress management techniques by a ... the traditional healthcare system of India. It is based ... the basis for all optimum health. Ayurveda believes that ...
(Date:5/18/2013)... 18, 2013 The American Society ... A. Kitzhaber, M.D., (D) to sign a bill (HB ... minors under the age of 18 from tanning indoors. ... third state in the nation to enact an under-18 ... indoor tanning bans for minors. Nationwide, 34 states and ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Dr. Robert Tracey, ... apnea dentistry, employs his knowledge of the root causes ... apnea patients. With May being Better Sleep Month, Dr. Tracey ... sort of chronic sleep disorder, and sleep apnea is one ... apnea, a person will essentially stop breathing at different times ...
Breaking Medicine News(10 mins):Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3
... 2008 at 11:00 a.m.,ET -, LOUISVILLE, Ky., Oct. 30 ... provider of home health nursing,services, announced today that it will ... on Wednesday, November 5, 2008, before the,market open., A ... a.m. ET on,November 5, 2008 and will be hosted by ...
... AMN Healthcare Services,Inc. (NYSE: AHS ) today announced operating ... Revenue of $315 million, up 5% over last year and 1% ... guidance. -- Revenue growth primarily driven by year-over-year volume increases ... & Allied and Locum Tenens. -- EPS of $0.28, up ...
... 30 HLTH Corporation,(Nasdaq: HLTH ) today ... 30, 2008., Martin J. Wygod, Chairman and ... HLTH,s 84% owned subsidiary, continues to,demonstrate its strength ... and health care professionals. WebMD,s third quarter advertising,sales, ...
... EPS of $0.53, Up 71% Versus Prior Year, As ... - Company Generates $67.3 Million of Cash from Operating Activities in ... Third Quarter - ... -, SAN DIEGO, Oct. 30 Gen-Probe Incorporated,(Nasdaq: GPRO ) today reported strong ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today reported financial ... reported a net loss allocable to common stockholders in the ... and a net loss,allocable to common stockholders in the first ... This compares with a net loss allocable to,common stockholders in ...
... Inc.,(Nasdaq: NUVO ) today announced third quarter 2008 financial ... 2008, Nuvelo reported a net,loss of $8.5 million or $0.16 ... per share for the same period in 2007. For the ... of $27.2 million or,$0.51 per share, compared with net loss ...
Cached Medicine News:Health News:Almost Family, Inc. to Report Third Quarter 2008 Financial Results 2Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 2Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 3Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 4Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 5Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 6Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 7Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 8Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 9Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 10Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 11Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 12Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 13Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 14Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 15Health News:HLTH Corporation Announces Third Quarter Financial Results 2Health News:HLTH Corporation Announces Third Quarter Financial Results 3Health News:HLTH Corporation Announces Third Quarter Financial Results 4Health News:HLTH Corporation Announces Third Quarter Financial Results 5Health News:HLTH Corporation Announces Third Quarter Financial Results 6Health News:HLTH Corporation Announces Third Quarter Financial Results 7Health News:HLTH Corporation Announces Third Quarter Financial Results 8Health News:HLTH Corporation Announces Third Quarter Financial Results 9Health News:HLTH Corporation Announces Third Quarter Financial Results 10Health News:HLTH Corporation Announces Third Quarter Financial Results 11Health News:HLTH Corporation Announces Third Quarter Financial Results 12Health News:HLTH Corporation Announces Third Quarter Financial Results 13Health News:HLTH Corporation Announces Third Quarter Financial Results 14Health News:HLTH Corporation Announces Third Quarter Financial Results 15Health News:HLTH Corporation Announces Third Quarter Financial Results 16Health News:HLTH Corporation Announces Third Quarter Financial Results 17Health News:HLTH Corporation Announces Third Quarter Financial Results 18Health News:Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance 2Health News:Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance 3Health News:Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance 4
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
Medicine Products: